{
    "nctId": "NCT02009150",
    "briefTitle": "Evaluation of a Novel Infra-red Breast Imaging System for Risk Assessment in Women at High Risk for Breast Cancer.",
    "officialTitle": "Evaluation of REAL IMAGING'S 3D Functional Metabolic Imaging and Risk Assessment (\"3D MIRA\") System in Women at High Risk for Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 236,
    "primaryOutcomeMeasure": "Diagnostic accuracy of 3D MIRA as a breast imaging aid in women with a high risk of breast cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female\n* Woman has read, understood and signed the inform consent form\n* Age: 20 years and older\n* Women who are asymptomatic for breast cancer\n* Proven carriers of deleterious BRCA1 or BRCA2 mutations Or Women that were found to have a lifetime risk of developing breast cancer greater or equal to 20% based on Tyrer-Cuzick, Gail or Clause risk models\n* Women scheduled to undergo routine mammography and/or US or MRI screening\n\nExclusion Criteria:\n\n* Women who have had a mammography and/or ultrasound examination performed on the day of the study prior to MIRA scan\n* Women who had a lumpectomy surgery\n* Women who had undergone mastectomy and/or reconstruction\n* Women who have undergone any type of breast surgery throughout the 6 months preceding the study\n* Women who have had a breast biopsy performed throughout the 10 weeks preceding the study.\n* Women who have a fever on the day of the MIRA imaging\n* Women who are pregnant\n* Women who are breast-feeding\n* Women who had undergone breast reduction/augmentation",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}